-
2
-
-
84906354978
-
Non-Vitamin K antagonist oral anticoagulants (NOACs): Clinical evidence and therapeutic considerations
-
K. Saraf, P. Morris, P. Garg, P. Sheridan, and R. Storey Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations Postgrad. Med. J. 90 1067 2014 520 528
-
(2014)
Postgrad. Med. J.
, vol.90
, Issue.1067
, pp. 520-528
-
-
Saraf, K.1
Morris, P.2
Garg, P.3
Sheridan, P.4
Storey, R.5
-
3
-
-
84894295323
-
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis
-
S. Schulman, A.K. Kakkar, S.Z. Goldhaber, S. Schellong, H. Eriksson, P. Mismetti, and et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis Circulation 129 7 2014 764 772
-
(2014)
Circulation
, vol.129
, Issue.7
, pp. 764-772
-
-
Schulman, S.1
Kakkar, A.K.2
Goldhaber, S.Z.3
Schellong, S.4
Eriksson, H.5
Mismetti, P.6
-
4
-
-
84894222894
-
Treatment of venous thromboembolism
-
P.S. Wells, M.A. Forgie, and M.A. Rodger Treatment of venous thromboembolism JAMA 311 7 2014 717 728
-
(2014)
JAMA
, vol.311
, Issue.7
, pp. 717-728
-
-
Wells, P.S.1
Forgie, M.A.2
Rodger, M.A.3
-
5
-
-
84908270185
-
Evaluation of Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism Using a Mixed-Treatment Comparison, Meta-Analytic Approach
-
B.M. Rollins, M.A. Silva, J.L. Donovan, and A.O. Kanaan Evaluation of Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism Using a Mixed-Treatment Comparison, Meta-Analytic Approach Clin. Ther. 10 2014 1454 1464
-
(2014)
Clin. Ther.
, Issue.10
, pp. 1454-1464
-
-
Rollins, B.M.1
Silva, M.A.2
Donovan, J.L.3
Kanaan, A.O.4
-
6
-
-
84908349388
-
Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials
-
S.K. Kakkos, G.I. Kirkilesis, and I.A. Tsolakis Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials Eur. J. Vasc. Endovasc. Surg. 5 2014 565 575
-
(2014)
Eur. J. Vasc. Endovasc. Surg.
, Issue.5
, pp. 565-575
-
-
Kakkos, S.K.1
Kirkilesis, G.I.2
Tsolakis, I.A.3
-
7
-
-
84904533958
-
Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism
-
G. Agnelli, and C. Becattini Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism Hematol. Am. Soc. Hematol. Educ. Program 2013 2013 471 477
-
(2013)
Hematol. Am. Soc. Hematol. Educ. Program
, vol.2013
, pp. 471-477
-
-
Agnelli, G.1
Becattini, C.2
-
8
-
-
84873596181
-
Apixaban for extended treatment of venous thromboembolism
-
G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, M. Johnson, and et al. Apixaban for extended treatment of venous thromboembolism N. Engl. J. Med. 368 8 2013 699 708
-
(2013)
N. Engl. J. Med.
, vol.368
, Issue.8
, pp. 699-708
-
-
Agnelli, G.1
Buller, H.R.2
Cohen, A.3
Curto, M.4
Gallus, A.S.5
Johnson, M.6
-
9
-
-
84884548759
-
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: Systematic review and network meta-analysis
-
L.A. Castellucci, C. Cameron, G. Le Gal, M.A. Rodger, D. Coyle, P.S. Wells, and et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis BMJ 347 2013 f5133
-
(2013)
BMJ
, vol.347
, pp. f5133
-
-
Castellucci, L.A.1
Cameron, C.2
Le Gal, G.3
Rodger, M.A.4
Coyle, D.5
Wells, P.S.6
-
10
-
-
84859001212
-
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
-
J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, and et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
-
(2011)
BMJ
, vol.343
, pp. d5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
Juni, P.4
Moher, D.5
Oxman, A.D.6
-
11
-
-
84872011968
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration
-
A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J. Clin. Epidemiol. 62 10 2009 e1 e34
-
(2009)
J. Clin. Epidemiol.
, vol.62
, Issue.10
, pp. e1-e34
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
Mulrow, C.4
Gotzsche, P.C.5
Ioannidis, J.P.6
-
13
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, A.S. Gallus, and et al. Oral rivaroxaban for symptomatic venous thromboembolism N. Engl. J. Med. 363 26 2010 2499 2510
-
(2010)
N. Engl. J. Med.
, vol.363
, Issue.26
, pp. 2499-2510
-
-
Bauersachs, R.1
Berkowitz, S.D.2
Brenner, B.3
Buller, H.R.4
Decousus, H.5
Gallus, A.S.6
-
14
-
-
84874003257
-
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism
-
S. Schulman, C. Kearon, A.K. Kakkar, S. Schellong, H. Eriksson, D. Baanstra, and et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism N. Engl. J. Med. 368 8 2013 709 718
-
(2013)
N. Engl. J. Med.
, vol.368
, Issue.8
, pp. 709-718
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Schellong, S.4
Eriksson, H.5
Baanstra, D.6
-
15
-
-
0035913237
-
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators
-
G. Agnelli, P. Prandoni, M.G. Santamaria, P. Bagatella, A. Iorio, M. Bazzan, and et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators N. Engl. J. Med. 345 3 2001 165 169
-
(2001)
N. Engl. J. Med.
, vol.345
, Issue.3
, pp. 165-169
-
-
Agnelli, G.1
Prandoni, P.2
Santamaria, M.G.3
Bagatella, P.4
Iorio, A.5
Bazzan, M.6
-
16
-
-
0033602514
-
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
-
C. Kearon, M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, D.R. Anderson, and et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N. Engl. J. Med. 340 12 1999 901 907
-
(1999)
N. Engl. J. Med.
, vol.340
, Issue.12
, pp. 901-907
-
-
Kearon, C.1
Gent, M.2
Hirsh, J.3
Weitz, J.4
Kovacs, M.J.5
Anderson, D.R.6
-
17
-
-
55549088596
-
Venous thromboembolism in the elderly. A community-based perspective
-
F.A. Spencer, J.M. Gore, D. Lessard, C. Emery, L. Pacifico, G. Reed, and et al. Venous thromboembolism in the elderly. A community-based perspective Thromb. Haemost. 100 5 2008 780 788
-
(2008)
Thromb. Haemost.
, vol.100
, Issue.5
, pp. 780-788
-
-
Spencer, F.A.1
Gore, J.M.2
Lessard, D.3
Emery, C.4
Pacifico, L.5
Reed, G.6
-
18
-
-
84880769850
-
Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: Systematic review and meta-analyses of randomized controlled trials
-
P. Sardar, S. Chatterjee, and D. Mukherjee Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials Drugs 73 11 2013 1171 1182
-
(2013)
Drugs
, vol.73
, Issue.11
, pp. 1171-1182
-
-
Sardar, P.1
Chatterjee, S.2
Mukherjee, D.3
-
19
-
-
84925011405
-
Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: Network meta-analysis
-
G. Alotaibi, K. Alsaleh, C. Wu, and M.S. McMurtry Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis Int. Angiol. 33 4 2014 301 308
-
(2014)
Int. Angiol.
, vol.33
, Issue.4
, pp. 301-308
-
-
Alotaibi, G.1
Alsaleh, K.2
Wu, C.3
McMurtry, M.S.4
-
20
-
-
8044235654
-
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
-
S. Schulman, S. Granqvist, M. Holmström, A. Carlsson, P. Lindmarker, P. Nicol, and et al. The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism N. Engl. J. Med. 336 6 1997 393 398
-
(1997)
N. Engl. J. Med.
, vol.336
, Issue.6
, pp. 393-398
-
-
Schulman, S.1
Granqvist, S.2
Holmström, M.3
Carlsson, A.4
Lindmarker, P.5
Nicol, P.6
-
21
-
-
23844472994
-
Evidence from clinical trials: Can we do better?
-
A.D. Siderowf Evidence from clinical trials: can we do better? NeuroRx 1 3 2004 363 371
-
(2004)
NeuroRx
, vol.1
, Issue.3
, pp. 363-371
-
-
Siderowf, A.D.1
-
22
-
-
84903775609
-
Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: Comparison and critique of study methodology and results
-
A.T. Cohen, S. Imfeld, and T. Rider Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: comparison and critique of study methodology and results Adv. Ther. 31 5 2014 473 493
-
(2014)
Adv. Ther.
, vol.31
, Issue.5
, pp. 473-493
-
-
Cohen, A.T.1
Imfeld, S.2
Rider, T.3
-
23
-
-
84895541979
-
Non-Vitamin K antagonist oral anticoagulants in cardiovascular disease management: Evidence and unanswered questions
-
J.W. Cheng, and G. Barillari Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions J. Clin. Pharm. Ther. 39 2 2014 118 135
-
(2014)
J. Clin. Pharm. Ther.
, vol.39
, Issue.2
, pp. 118-135
-
-
Cheng, J.W.1
Barillari, G.2
-
24
-
-
84876226603
-
New oral anticoagulants: Comparative pharmacology with Vitamin K antagonists
-
F. Scaglione New oral anticoagulants: comparative pharmacology with vitamin K antagonists Clin. Pharmacokinet. 52 2 2013 69 82
-
(2013)
Clin. Pharmacokinet.
, vol.52
, Issue.2
, pp. 69-82
-
-
Scaglione, F.1
-
25
-
-
84927518854
-
The treatment of venous thromboembolism with novel oral anticoagulants: Warnings and limitations
-
P. Prandoni The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations Blood Transfus. 13 2 2015 178 180
-
(2015)
Blood Transfus.
, vol.13
, Issue.2
, pp. 178-180
-
-
Prandoni, P.1
-
26
-
-
84904764432
-
Novel oral anticoagulants in patients with renal insufficiency: A meta-analysis of randomized trials
-
P. Sardar, S. Chatterjee, E. Herzog, R. Nairooz, D. Mukherjee, and J.L. Halperin Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials Can. J. Cardiol. 30 8 2014 888 897
-
(2014)
Can. J. Cardiol.
, vol.30
, Issue.8
, pp. 888-897
-
-
Sardar, P.1
Chatterjee, S.2
Herzog, E.3
Nairooz, R.4
Mukherjee, D.5
Halperin, J.L.6
-
27
-
-
33748622029
-
New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism
-
S. Schulman, and M. Ogren New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism Thromb. Haemost. 96 3 2006 258 266
-
(2006)
Thromb. Haemost.
, vol.96
, Issue.3
, pp. 258-266
-
-
Schulman, S.1
Ogren, M.2
-
28
-
-
84859385808
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
-
H.R. Buller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, E. Minar, and et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N. Engl. J. Med. 366 14 2012 1287 1297
-
(2012)
N. Engl. J. Med.
, vol.366
, Issue.14
, pp. 1287-1297
-
-
Buller, H.R.1
Prins, M.H.2
Lensin, A.W.3
Decousus, H.4
Jacobson, B.F.5
Minar, E.6
-
29
-
-
84907221429
-
Clinical and safety outcomes associated with treatment of acute venous thromboembolism: A systematic review and meta-analysis
-
L.A. Castellucci, C. Cameron, G. Le Gal, M.A. Rodger, D. Coyle, P.S. Wells, and et al. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis JAMA 312 11 2014 1122 1135
-
(2014)
JAMA
, vol.312
, Issue.11
, pp. 1122-1135
-
-
Castellucci, L.A.1
Cameron, C.2
Le Gal, G.3
Rodger, M.A.4
Coyle, D.5
Wells, P.S.6
-
30
-
-
71849117615
-
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
-
S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, H. Eriksson, and et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N. Engl. J. Med. 361 24 2009 2342 2352
-
(2009)
N. Engl. J. Med.
, vol.361
, Issue.24
, pp. 2342-2352
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Mismetti, P.4
Schellong, S.5
Eriksson, H.6
-
31
-
-
84880327613
-
Oral apixaban for the treatment of acute venous thromboembolism
-
G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, M. Johnson, and et al. Oral apixaban for the treatment of acute venous thromboembolism N. Engl. J. Med. 369 9 2013 799 808
-
(2013)
N. Engl. J. Med.
, vol.369
, Issue.9
, pp. 799-808
-
-
Agnelli, G.1
Buller, H.R.2
Cohen, A.3
Curto, M.4
Gallus, A.S.5
Johnson, M.6
-
32
-
-
78049398953
-
Systematic review and meta-analysis methodology
-
M. Crowther, W. Lim, and M.A. Crowther Systematic review and meta-analysis methodology Blood 116 17 2010 3140 3146
-
(2010)
Blood
, vol.116
, Issue.17
, pp. 3140-3146
-
-
Crowther, M.1
Lim, W.2
Crowther, M.A.3
|